billHR10731•Event Monday, October 5, 2026Analyzed

To adjust the cost pass-through for certified registered nurse anesthetists under the Medicare program.

Neutral

Summary

HR10731, introduced by Rep. Davids on October 5, 2026, proposes adjustments to Medicare cost pass-through for certified registered nurse anesthetists. The bill is in early stages, referred to the House Committee on Ways and Means with no cosponsors. Its narrow scope and early legislative stage suggest minimal near-term market impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Early-stage bill with no cosponsors indicates low legislative momentum.
  • 2.Narrow focus on Medicare CRNA payment adjustment limits sector impact.
  • 3.No funding authorization; potential impact depends on subsequent committee action and bill text.

Market Implications

Given the early stage and narrow scope, no immediate market implications. If the bill advances, it could affect hospital margins on anesthesia services, but current probability of passage is low. Without bill text, the direction of impact on any specific company is unknown.

Full Analysis

HR10731 is a narrow bill that would adjust the cost pass-through for certified registered nurse anesthetists under Medicare. Introduced on October 5, 2026, it was referred to the House Committee on Ways and Means, the primary tax and healthcare financing committee. The sponsor, Rep. Sharice Davids (D-KS-3), is a junior member with no cosponsors, indicating limited initial support. The bill has no explicit funding authorization; it modifies payment methodology rather than appropriating funds. As an early-stage bill, it faces a long legislative path: committee markup, potential amendments, House floor vote, Senate consideration, and presidential action. Given the lack of companion legislation and the narrow focus on Medicare payment mechanics, the probability of enactment in its current form is low. The primary stakeholders are hospital systems and anesthesia providers that bill Medicare for CRNA services, but without bill text specifying the direction of adjustment, the impact on any particular company is indeterminate. Investors should monitor committee activity for signs of momentum, but no immediate market action is warranted.

Key Legislators

Rep. Davids, Sharice [D-KS-3]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →